Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Enhancement of serotonin neurotransmission plays an important role in the antidepressant response to agents presently available to treat depression. This response forms the major evidence for the role of serotonin in affective and social behaviour in humans. The present study investigated the effects of acute administration of the selective serotonin reuptake inhibitor (SSR1), citalopram (10 mg, i.v.) upon a measure of emotional processing in healthy female volunteers. Subjects completed a facial expression recognition task following infusion of citalopram or saline (between-subjects design, double-blind). Facial expressions associated with five basic emotions--happiness, sadness, fearfulness, anger and disgust--were displayed. Each face had been 'morphed' between neutral (0%) and each emotional standard (100%) in 10% steps, leading to a range of emotional intensities. Mood and subjective experience were also monitored throughout the testing session. Volunteers receiving citalopram detected a higher number of facial expressions of fear and happiness, with reduced response times, relative to those given the placebo. By contrast, changes in the recognition of other basic emotions were not observed following citalopram. Notable differences in mood were also not apparent in these volunteers. These results suggest that acute administration of antidepressant drugs may affect neural processes involved in the processing of social information. This effect may represent an early acute…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have previously shown that acute and sub-chronic SSRI intervention affects emotion recognition, specifically for recognition of fear and happiness [22].”
From Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study (2023) · cites this paper as [22]
In the citing paper
“Studies examining the acute administration of SSRIs have shown impaired probabilistic learning [19, 20], and impaired cognitive flexibility [20], but increased long-term memory recall [21], emotion recognition [22], and harm aversion for moral judgements [23].”
From Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study (2023) · cites this paper as [22]
In the citing paper
“Some studies suggest that SSRIs have acute or subacute effects on cognition, e.g., affective processing bias [25–27]”
From Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial (2023) · cites this paper as [25]
In the citing paper
“have been demonstrated to reduce negative and to increase positive biases in non-clinical groups (Harmer et al, 2003; Murphy et al, 2009).”
From Using an Experimental Medicine Model to Explore Combination Effects of Pharmacological and Cognitive Interventions for Depression and Anxiety (2011) · cites this paper as Harmer et al, 2003
In the citing paper
“Studies considering the effects of a single dose of citalopram give more complex results, since they appear to show not only increases in happy recognition,32 but also increases in the processing of fearful expressions.28,32”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [32]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An argument for basic emotions
Ekman, P. (1992) · Cognition and Emotion · doi:10.1080/02699939208411068 · Cited by 9,646
The amygdala: vigilance and emotion
Davis, M., & Whalen, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000812 · Cited by 2,882
Adolphs, R., Tranel, D., Damasio, H., & Damasio, A. (1994) · Nature · doi:10.1038/372669a0 · Cited by 2,360
A differential neural response in the human amygdala to fearful and happy facial expressions
Morris, J. S., Frith, C. D., Perrett, D. I., Rowland, D., Young, A. W., Calder, A. J., & Dolan, R. J. (1996) · Nature · doi:10.1038/383812a0 · Cited by 2,013
Self-citationA specific neural substrate for perceiving facial expressions of disgust
Phillips, M. L., Young, A. W., Senior, C., Brammer, M., Andrew, C., Calder, A. J., Bullmore, E. T., Perrett, D. I., Rowland, D., Williams, S. C. R., et al. (1997) · Nature · doi:10.1038/39051 · Cited by 1,609 · cited 2×
“Insula and basal ganglia damage has also been associated with an impairment in the recognition of facial and vocal signs of disgust (Calder et al, 2000) and, consistent with this, the anterior insula shows increased activity when viewing disgusted facial expressions (Phillips et al, 1997, 1998).”
BackgroundResultSelf-citationNeurobiology of Pavlovian fear conditioning
Maren, S. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.897 · Cited by 1,543
A functional anatomical study of unipolar depression
Drevets, W., Videen, T., Price, J., Preskorn, S., Carmichael, S., & Raichle, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03628.1992 · Cited by 1,266
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Rauch, S. L., Whalen, P. J., Shin, L. M., McInerney, S. C., Macklin, M. L., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00828-3 · Cited by 1,111
Research works printed but not linked: 1
- Ekman P, Friesen WV (1976). Pictures of Facial Affect Consulting Psychology. Palo Alto, CA.
Cited by
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
Serotoninergic regulation of emotional and behavioural control processes
Cools, R., Roberts, A. C., & Robbins, T. W. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.10.011 · Cited by 656
“Rarely have investigators capitalized on the different effects in studies of cognitive or affective functions in healthy volunteers (but see Refs [27,75] and text).”
Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 648
“Altered immobility in the FST and the TST, however, may model behavioral effects observed during early antidepressant treatment in humans with MDD (Katz et al., 1987; Harmer et al., 2003a, b).”
BackgroundHarmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554
Self-citationHarmer, C. J., Goodwin, G. M., & Cowen, P. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051193 · Cited by 542
“22,23 In addition, citalopram increased attention to positive socially relevant stimuli in a visual probe task after a single administration.”
BackgroundSelf-citationCognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Serotonin selectively influences moral judgment and behavior through effects on harm aversion
Crockett, M. J., Clark, L., Hauser, M. D., & Robbins, T. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009396107 · Cited by 526
“Empathic neural responses to others’ suffering involve the insula (3, 49), which receives a high density of serotonin modulation (17), and serotonin manipulations influence the detection of emotion in faces (55), which has been linked to trait empathy (56).”
BackgroundSchmidt, K., Cowen, P. J., Harmer, C. J., Tzortzis, G., Errington, S., & Burnet, P. W. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3810-0 · Cited by 522
Self-citationThe neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
“Single doses of SSRIs do not reverse negative nformation-processing biases: on the contrary, responses to threat re increased (Harmer et al., 2003a; Browning et al., 2007).”
BackgroundEffect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients
Harmer, C. J., O’Sullivan, U., Favaron, E., Massey-Chase, R., Ayres, R., Reinecke, A., Goodwin, G. M., & Cowen, P. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020149 · Cited by 485
“Similar effects on the recognition of happy facial expressions have been seen with acute administration of both the serotonin reuptake inhibitor citalopram (9, 10) and the serotonin and norepinephrine reuptake inhibitor duloxetine (11), which suggests that such changes in emotional processing may be a common effect of…”
BackgroundSelf-citationMDMA enhances emotional empathy and prosocial behavior
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst161 · Cited by 356
Affective Cognition and its Disruption in Mood Disorders
Elliott, R., Zahn, R., Deakin, J. F. W., & Anderson, I. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.77 · Cited by 330
Cryan, J. F., Page, M. E., & Lucki, I. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0093-5 · Cited by 321
“There is also evidence that some behavioral changes observed in patients early on in clinical treatments may predict or at least be relevant to positive therapeutic outcome later (Harmer et al. 2003; Katz et al. 2004).”
BackgroundMinzenberg, M. J., Fan, J., New, A. S., Tang, C. Y., & Siever, L. J. (2007) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2007.03.006 · Cited by 317
“Doubleblind, placebo-controlled studies indicate that serotonergic agents can modulate healthy adults' ability to recognize facial expressions of fear (Harmer et al., 2003, 2004; Attenburrow et al., 2003).”
BackgroundMethodInfluentialKometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., & Vollenweider, F. X. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.005 · Cited by 298
Impaired attribution of emotion to facial expressions in anxiety and major depression
Demenescu, L. R., Kortekaas, R., den Boer, J. A., & Aleman, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015058 · Cited by 292
“Medication use might have been a confounding variable because manipulation of the serotonin system, which is a common antidepressant treatment, produces specific alterations in the ability to recognize fear [62].”
BackgroundStoy, M., Schlagenhauf, F., Sterzer, P., Bermpohl, F., Hägele, C., Suchotzki, K., Schmack, K., Wrase, J., Ricken, R., Knutson, B., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111416686 · Cited by 279
“Together these results are consistent with findings indicating an indirect delayed improvement of depressive symptoms via enhanced emotional information processing after antidepressant treatment (Harmer et al., 2003, 2008).”
ResultSerotonin, inhibition, and negative mood
Dayan, P., & Huys, Q. J. M. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0040004 · Cited by 263
“fearful faces with increasing serotonin [58,68,70], whereas a more chronic increase in 5-HT (via SSRIs) yields a decrease in”
Effect of a single dose of citalopram on amygdala response to emotional faces
Murphy, S. E., Norbury, R., O'Sullivan, U., Cowen, P. J., & Harmer, C. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056093 · Cited by 255
“…expected increase in the recognition of happy facial expressions on the behavioural facial expression recognition task but, unlike participants in a number of previous studies of acute serotonergic manipulation, 4,5,36 they did not show an increase in the recognition of fearful facial expressions.”
InfluentialSelf-citationDel-Ben, C. M., Deakin, J. F. W., Mckie, S., Delvai, N. A., Williams, S. R., Elliott, R., Dolan, M., & Anderson, I. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300728 · Cited by 260
“Therefore, we do not know whether our subjects would have behavioral data comparable with Harmer et al (2003a).”
BackgroundInfluentialHarmer, C. J., Hill, S. A., Taylor, M. J., Cowen, P. J., & Goodwin, G. M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.990 · Cited by 262
“Recognition of facial expression was assessed as previously described (4).”
MethodSelf-citationEffects of tryptophan loading on human cognition, mood, and sleep
Silber, B. Y., & Schmitt, J. A. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.005 · Cited by 260
“The available reports suggest that Trp loading in females can induce a positive bias in the processing of emotional stimuli, which is consistent with the effects of serotonergic antidepressants (Harmer et al., 2003, 2004, 2006).”
ResultBurghardt, N. S., Sullivan, G. M., McEwen, B. S., Gorman, J. M., & LeDoux, J. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.029 · Cited by 246
A single dose of citalopram increases fear recognition in healthy subjects
Browning, M., Reid, C., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106074062 · Cited by 245
Self-citationDi Simplicio, M., Massey-Chase, R., Cowen, P., & Harmer, C. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108095705 · Cited by 229
Serotonin and emotional processing: does it help explain antidepressant drug action?
Harmer, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.036 · Cited by 219
Self-citationLongitudinal Assessment of Neuropsychological Function in Major Depression
Douglas, K. M., & Porter, R. J. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903279887 · Cited by 217
Escitalopram effects on insula and amygdala BOLD activation during emotional processing
Arce, E., Simmons, A. N., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1004-8 · Cited by 198
“2007) and intravenous (Harmer et al. 2003) administration of the SSRI citalopram increases the processing of anxiety-related stimuli in healthy volunteers, whereas repeated administration impairs the recognition of fearful stimuli (Harmer et al.”
BackgroundInfluentialBhagwagar, Z., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.166 · Cited by 189
“The facial expression recognition task, described previously (3), featured examples of five basic emotions—happiness, sadness, fear, anger, and disgust (4)—which had been averaged between neutral (0%) and each emotional standard (100%) in 10% steps, providing a range of emotional intensities.”
BackgroundSelf-citationNeuropsychological Impairment in Major Depression: Its Nature, Origin and Clinical Significance
Porter, R. J., Bourke, C., & Gallagher, P. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601109881 · Cited by 236
“manipulations on emotional processing [68,69].”
Tranter, R., Bell, D., Gutting, P., Harmer, C., Healy, D., & Anderson, I. M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.028 · Cited by 184
Self-citationHindocha, C., Freeman, T. P., Schafer, G., Gardener, C., Das, R. K., Morgan, C. J. A., & Curran, H. V. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.014 · Cited by 183
“The markers were then placed onto the actor's emotional expression and morphed between the full emotion (100%) and neutral (0%) in 10% increments and stills were taken at these points (Harmer et al., 2003).”
Harmer, C. J., & Cowen, P. J. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0407 · Cited by 183
“In a task of emotional processing, we found that a single dose of the SSRI, citalopram (20 mg), increased the recognition of happy facial expressions [22].”
BackgroundSelf-citationMacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181
“…single-dose effects of lifesaving psychiatric medications [i.e., antipsychotics, serotonin reuptake inhibitors (SSRIs)] are often either negligible (Harmer et al., 2003; Murphy et al., 2009) or aversive (Belmaker and Wald, 1977; Harmer et al., 2008); (3) in psychiatric patients, the short-term…”
BackgroundSocial-emotion recognition in borderline personality disorder
Minzenberg, M. J., Poole, J. H., & Vinogradov, S. (2006) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.03.005 · Cited by 175
“Harmer et al have found that recognition of fearful facial expressions by healthy adults is enhanced with administration of either tryptophan [47] or selective serotonin reuptake inhibitors [48] and decreased with tryptophan depletion [49].”
BackgroundKemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170
Tryptophan depletion decreases the recognition of fear in female volunteers
Harmer, C. J., Rogers, R. D., Tunbridge, E., Cowen, P. J., & Goodwin, G. M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1401-6 · Cited by 163
“Using a different paradigm, we have observed that acute administration of the selective serotonin re-uptake inhibitor (SSRI) citalopram (10 mg, IV) increased the recognition of fear cues from facial expression (Harmer et al. 2003).”
BackgroundResultInfluentialSelf-citationGrillon, C., Levenson, J., & Pine, D. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301204 · Cited by 162
“This effect is consistent with clinical reports of symptom exacerbation following treatment initiation (Gorman et al, 1987; Ramos et al, 1993) and with evidence of facilitation of processing threat cues in experimental models following acute SSRIs (Burghardt et al, 2004; Harmer et al, 2003b).”
BackgroundResultInfluentialA model of differential amygdala activation in psychopathy
Moul, C., Killcross, S., & Dadds, M. R. (2012) · Psychological Review · doi:10.1037/a0029342 · Cited by 159
Cools, R., Calder, A. J., Lawrence, A. D., Clark, L., Bullmore, E., & Robbins, T. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2215-5 · Cited by 161
“Whilst concurring with the present amygdala activation profile, this pattern appears inconsistent with findings from Harmer et al. (2003b) and Attenburrow et al. (2003) who observed, respectively, that acute tryptophan depletion reduced and acute tryptophan loading enhanced fear perception in a…”
BackgroundResultInfluentialEmotion recognition and genetic vulnerability to schizophrenia
Bediou, B., Asri, F., Brunelin, J., Krolak-Salmon, P., D'Amato, T., Saoud, M., & Tazi, I. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.028829 · Cited by 159
Optogenetic insights on the relationship between anxiety-related behaviors and social deficits
Allsop, S. A., Vander Weele, C. M., Wichmann, R., & Tye, K. M. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00241 · Cited by 150
“Additionally, selective serotonin reuptake inhibitors (SSRIs), which increase serotonin concentration, have been shown to have enhancing effects on complex social behaviors (Knutson et al., 1998; Harmer, 2002) and have been used for treating general anxiety disorder as well as social anxiety disorder (Stein et al.”
BackgroundRodent tests of depression and anxiety: Construct validity and translational relevance
Gencturk, S., & Ünal, G. (2024) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-024-01171-2 · Cited by 175
“Differences in social cue processing (Harmer, Bhagwagar et al., 2003a, 2003b) and emotional bias (Harmer, Hill et al., 2003a, 2003b) are observed before the common ameliorative effects of antidepressants.”
BackgroundA cognitive neuropsychological model of antidepressant drug action
Pringle, A., Browning, M., Cowen, P. J., & Harmer, C. J. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.022 · Cited by 130
Self-citationIronside, M., O’Shea, J., Cowen, P. J., & Harmer, C. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.012 · Cited by 125
“Recognition of facial expression, emotional categorisation and memory were assessed as previously described [37] (see Supplemental Information).”
Self-citationCitalopram modulation of neuronal responses to aversive face emotions: a functional MRI study
Anderson, I. M., Del-Ben, C. M., Mckie, S., Richardson, P., Williams, S. R., Elliott, R., & William Deakin, J. F. (2007) · NeuroReport · doi:10.1097/wnr.0b013e3282742115 · Cited by 129
“This appears inconsistent with behavioural studies, which have suggested 5-HT positively modulates recognition of fearful faces in women [3,4].”
BackgroundResultEfficacy markers in depression
Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367722 · Cited by 122
“Hence, acute reboxetine, mirtazapine and duloxetine and repeated administration of reboxetine and citalopram all increase the recall of positive versus negative stimuli in this task in healthy volunteers (Arnone et al., 2009; Harmer et al., 2003b, 2004, 2008).”
BackgroundInfluentialSelf-citationGodlewska, B. R., & Harmer, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-019-05448-0 · Cited by 123
Self-citationPutting Pain Assessment into Practice: Why Is It so Painful?
Franck, L. S., & Bruce, E. (2009) · Pain Research and Management · doi:10.1155/2009/856587 · Cited by 126
“Natural and drug-induced mood states also interfere with accurate detection of emotional expression in others (33-35).”
BackgroundModelling cognitive affective biases in major depressive disorder using rodents
Hales, C. A., Stuart, S. A., Anderson, M. H., & Robinson, E. S. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12603 · Cited by 139
“In fact, the recent observation that acute treatment with antidepressant and prodepressant drugs in healthy volunteers can cause CABs (e.g. Harmer et al., 2003; 2004; 2009b; see Pringle et al., 2011) suggests that antidepressant drugs may well have acute effects on these emotional processes which…”
BackgroundInfluentialRisk for depression and neural responses to fearful facial expressions of emotion
Chan, S. W. Y., Norbury, R., Goodwin, G. M., & Harmer, C. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.047993 · Cited by 117
“This probably represents maximal ambiguity as behavioural data suggests that low intensity levels are usually perceived as neutral and high intensity levels usually elicit ceiling levels of performance, with the longest reaction time to identify facial expressions being seen around mid-intensity level (50, 51).”
Self-citationKalafatakis, K., Russell, G. M., Harmer, C. J., Munafo, M. R., Marchant, N., Wilson, A., Brooks, J. C. W., Durant, C. F., Thakrar, J., Murphy, P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714239115 · Cited by 133
Self-citationA specific role for serotonin in overcoming effort cost
Meyniel, F., Goodwin, G. M., Deakin, J. F. W., Klinge, C., MacFadyen, C., Milligan, H., Mullings, E. L., Pessiglione, M., & Gaillard, R. (2016) · eLife · doi:10.7554/elife.17282 · Cited by 136
“However, at the molecular level, serotonin release is boosted by SSRIs from treatment onset (Kobayashi et al., 2008) and SSRI effects on emotional processing also occur with little or no delay in healthy subjects (Harmer et al., 2003).”
BackgroundSelf-citationSelective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
Ye, Z., Altena, E., Nombela, C., Housden, C. R., Maxwell, H., Rittman, T., Huddleston, C., Rae, C. L., Regenthal, R., Sahakian, B. J., et al. (2014) · Brain · doi:10.1093/brain/awu032 · Cited by 134
“In the context of depression, single-dose SSRIs enhanced positive biases (e.g. citalopram) and decreased threat-relevant biases (e.g. mirtazapine) in emotional perception and memory (Harmer et al., 2003; Browning et al., 2007; Arnone et al., 2009; Rawlings et al., 2010).”
BackgroundNaranjo, C., Kornreich, C., Campanella, S., Noël, X., Vandriette, Y., Gillain, B., de Longueville, X., Delatte, B., Verbanck, P., & Constant, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.039 · Cited by 117
Facial emotion recognition impairment in chronic temporal lobe epilepsy
Meletti, S., Benuzzi, F., Cantalupo, G., Rubboli, G., Tassinari, C. A., & Nichelli, P. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01978.x · Cited by 122
“, 2001), selective serotonin reuptake inhibitors (SSRIs) (Harmer et al., 2003), or scopolamine (Kamboj & Curran, 2006), and produced rather conflicting results.”
BackgroundTakahashi, H., Yahata, N., Koeda, M., Takano, A., Asai, K., Suhara, T., & Okubo, Y. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.039 · Cited by 114
Shiroma, P. R., Thuras, P., Johns, B., & Lim, K. O. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4104 · Cited by 110
“Experiments in middle-aged healthy (Harmer et al., 2003; Harmer et al., 2004) and depressed subjects (Gorlyn et al., 2008; Harmer et al., 2009b) have shown improvement of emotion recognition biases after acute administration of antidepressant drugs (i.e., citalopram and reboxetine).”
BackgroundThe effects of serotonin manipulations on emotional information processing and mood
Merens, W., van der Does, W. A. J., & Spinhoven, P. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.032 · Cited by 123
“Harmer et al. (2003c) n = 38 healthy volunteers ATD vs. placebo - Facial expression recognition task - PANAS ATD impaired recognition of fear only in women.”
BackgroundMethodResultInfluentialvan der Wee, N. J., Veen, J. F. V., Stevens, H., van Vliet, I. M., van Rijk, P. P., & Westenberg, H. G. M. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045518 · Cited by 111
“recently reported an impaired recognition of fearful facial expression in female volunteers after tryptophan depletion, whereas acute administration of the SSRI citalopram to healthy volunteers increased the recognition of fearful faces (33,34).”
BackgroundVöllm, B., Richardson, P., McKie, S., Elliott, R., Deakin, J. F. W., & Anderson, I. M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04571.x · Cited by 106
“This is consistent with previous findings of facilitation of processing of rewarding stimuli (happy faces) after acute administration of citalopram by Harmer et al. (2003a). Tryptophan”
BackgroundResultSelf-citationShort- and Long-Term Functional Consequences of Fluoxetine Exposure During Adolescence in Male Rats
Iñiguez, S. D., Warren, B. L., & Bolaños‐Guzmán, C. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.033 · Cited by 124
Stroud, J., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D., Curran, H. V., & Carhart-Harris, R. L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4754-y · Cited by 126
Effects of alcohol on brain responses to social signals of threat in humans
Sripada, C. S., Angstadt, M., McNamara, P., King, A. C., & Phan, K. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.062 · Cited by 101
“Similar to the acute effects produced by pharmacologic agents often used in the treatment of excessive anxiety (Arce et al., 2008; Harmer et al., 2003; Paulus et al., 2005), we hypothesized that compared to placebo, alcohol would diminish amygdala reactivity to social signals of threat.”
Yildirim, B. O., & Derksen, J. J. L. (2015) · Aggression and Violent Behavior · doi:10.1016/j.avb.2015.05.001 · Cited by 143
Moul, C., Dobson‐Stone, C., Brennan, J., Hawes, D. J., & Dadds, M. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056619 · Cited by 111
“[13]”
Kemp, A. H., Gray, M. A., Silberstein, R. B., Armstrong, S. M., & Nathan, P. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.03.022 · Cited by 100
“Recently, Harmer et al. (2003a) reported that acute administration of the SSRI, citalopram (10 mg iv), facilitated the processing of happy facial expressions as evidenced by greater accuracy and reduced response times under citalopram relative to the placebo treatment.”
InfluentialSkandali, N., Rowe, J. B., Voon, V., Deakin, J. B., Cardinal, R. N., Cormack, F., Passamonti, L., Bevan-Jones, W. R., Regenthal, R., Chamberlain, S. R., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0229-z · Cited by 89
Acute administration of nutritionally sourced tryptophan increases fear recognition
Attenburrow, M.-J., Williams, C., Odontiadis, J., Reed, A., Powell, J., Cowen, P. J., & Harmer, C. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1479-x · Cited by 96
“In addition, based on a recent study with acute SSRI treatment, we predicted that acute TRP ingestion would increase the detection of fearful and happy facial expressions (Harmer et al. 2003a).”
BackgroundSelf-citationSlattery, D. A., & Neumann, I. D. (2010) · Pharmaceuticals · doi:10.3390/ph3030702 · Cited by 105
“These findings are in agreement with studies assessing the SSRIs, citalopram and reboxetine, in similar paradigms [122–124].”
ResultOmega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers
Antypa, N., van der Does, W. A. J., Smelt, A., & Rogers, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108092120 · Cited by 94
“For the decision-making task, proportionate choice data were arcsine-transformed.”
MethodMurphy, S. E., Yiend, J., Lester, K. J., Cowen, P. J., & Harmer, C. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009164 · Cited by 90
Self-citationSchmidt, A., Kometer, M., Bachmann, R. F., Seifritz, E., & Vollenweider, F. X. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2811-0 · Cited by 102
“It has been proposed that the enhanced fear detection in healthy subjects treated with citalopram (Harmer et al. 2003) may be partly due to an increased activity in the FG (Del-Ben et al.”
BackgroundEmotional processing in women with anorexia nervosa and in healthy volunteers
Jänsch, C., Harmer, C. J., & Cooper, M. J. (2009) · Eating Behaviors · doi:10.1016/j.eatbeh.2009.06.001 · Cited by 111
“The task was designed by Harmer and colleagues for use in a pharmacological study (Harmer et al., 2003), and no norms are available.”
BackgroundSelf-citationGrillon, C., Chavis, C., Covington, M. F., & Pine, D. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.141 · Cited by 88
“Most studies have examined the effect of a single dose of SSRIs (Harmer et al, 2003a; Kemp et al, 2004), but acute treatment may not inform on the anxiolytic effects of SSRI, which emerge only after chronic administration.”
Recognition of disgusted facial expressions in severe depression
Douglas, K. M., & Porter, R. J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078113 · Cited by 86
Booij, L., Van der Does, A. J. W., Haffmans, P. M. J., Riedel, W. J., Fekkes, D., & Blom, M. J. B. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051538 · Cited by 105
Challis, C., & Berton, O. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00007 · Cited by 98
Murphy, S. E., Longhitano, C., Ayres, R. E., Cowen, P. J., & Harmer, C. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0401-8 · Cited by 81
“…changes in the detection of facial expressions of emotion (Attenburrow et al. 2003) similar to those seen with acute citalopram administration (Harmer et al. 2003) Taken together, these findings suggest that, like serotonergic antidepressant agents, pharmacological doses of TRP can directly…”
ResultSelf-citationMiskowiak, K. W., Inkster, B., Selvaraj, S., Wise, R. G., Goodwin, G. M., & Harmer, C. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301439 · Cited by 82
“However, we have also hypothesized that acute increase in fear processing may relate to anxiogenic effects of SSRIs seen early in treatment (Harmer et al, 2003 ).”
Self-citationGirgenti, M. J., Hunsberger, J. G., Duman, C. H., Sathyanesan, M., Terwilliger, R. Z., & Newton, S. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.005 · Cited by 83
Stable expression recognition abnormalities in unipolar depression
Milders, M., Bell, S., Platt, J., Serrano, R., & Runcie, O. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.05.015 · Cited by 78
Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity
Klaassens, B. L., van Gorsel, H. C., Khalili-Mahani, N., van der Grond, J., Wyman, B. T., Whitcher, B., Rombouts, S. A. R. B., & van Gerven, J. M. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.012 · Cited by 76
Antidepressants in healthy subjects: What are the psychotropic/psychological effects?
Serretti, A., Calati, R., Goracci, A., Simplicio, M. C. D., Castrogiovanni, P., & Ronchi, D. D. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.009 · Cited by 88
Bollen, J. C., Trick, L., Llewellyn, D. J., & Dickens, C. M. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.01.002 · Cited by 88
Emotion Recognition Deficits in Pediatric Anxiety Disorders: Implications for Amygdala Research
Easter, J., Tone, E. B., Monk, C. S., Dhanani, M., Hodgdon, H., Leibenluft, E., Charney, D. S., Pine, D. S., & Ernst, M. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.563 · Cited by 96
Lavergne, F., Berlin, I., Gamma, A., Stassen, H. H., & Angst, J. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.1.1.59.52296 · Cited by 78
Yildirim, B. O., & Derksen, J. J. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.009 · Cited by 90
“, 2008), and improved recognition of fearful facial expressions (Browning et al., 2007; Harmer et al., 2003).”
BackgroundEarly effects of mirtazapine on emotional processing
Arnone, D., Horder, J., Cowen, P. J., & Harmer, C. J. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1410-6 · Cited by 74
“In contrast to both acute reboxetine (Harmer et al. 2003b) and duloxetine (Harmer et al. 2008), mirtazapine did not increase the recognition of happy facial expression but decreased the recognition of fear and also diminished overall startle responses.”
BackgroundResultInfluentialSelf-citationSocial Cognition in Bulimia Nervosa: A Systematic Review
DeJong, H., den Eynde, F. V., Broadbent, H. J., Kenyon, M., Lavender, A., Startup, H. M., & Schmidt, U. H. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.07.002 · Cited by 79
“For example, medication use is rarely reported [20,27], despite findings that antidepressant medication use affects facial emotion perception in both HCs and people with AN [18,19,25].”
BackgroundAdult hippocampal neurogenesis: Is it the alpha and omega of antidepressant action?
Eliwa, H., Belzung, C., & Surget, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.005 · Cited by 78
“Virtue Engineering” and Moral Agency: Will Post-Humans Still Need the Virtues?
Jotterand, F. (2011) · AJOB Neuroscience · doi:10.1080/21507740.2011.611124 · Cited by 88
“2005) and selective serotonin reuptake inhibitors (SSRIs) facilitate cooperation and reduce aggression (Harmer et al. 2003).”
BackgroundReinecke, A., Waldenmaier, L., Cooper, M. J., & Harmer, C. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.005 · Cited by 76
Self-citationErythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
Miskowiak, K. W., Vinberg, M., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2511-1 · Cited by 78
“The enhanced recognition of happiness and fear in EPO-treated volunteers is similar to acute effects of serotonergic antidepressants (Harmer et al. 2003) and in contrast with the decreased neural and behavioral response to fearful faces 1 week after EPO administration (Miskowiak et al.”
ResultSelf-citationHarmer, C. J., Heinzen, J., O’Sullivan, U., Ayres, R. A., & Cowen, P. J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1058-7 · Cited by 69
“Our previous studies suggest that administration of both serotonergic- and noradrenergic-specific antidepressants increase the recognition of happy facial expressions when given acutely to healthy volunteers (Murphy et al. 2006; Harmer et al. 2003a, b).”
BackgroundResultInfluentialSelf-citationKoenig, J., Parzer, P., Haigis, N., Liebemann, J., Jung, T., Resch, F., & Kaess, M. (2019) · Psychological Medicine · doi:10.1017/s0033291719003490 · Cited by 69
Gray colored glasses: Is major depression partially a sensory perceptual disorder?
Fitzgerald, P. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.045 · Cited by 81
“Acute or subchronic administration of serotonergic or noradrenergic antidepressants modulates behavioral recognition of facial expressions of particular emotions, both in healthy controls alone (Harmer et al., 2003; Harmer et al., 2004), and in depressed individuals relative to healthy controls (Harmer et al.”
BackgroundBooij, L., Merens, W., Markus, C. R., & van der Does, W. A. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105057466 · Cited by 78
Serotonin transporter polymorphisms (5-HTTLPR) in emotion processing
Jonassen, R., & Landrø, N. I. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.003 · Cited by 67
Metadata
- Authors
- Harmer, C. J., Bhagwagar, Z., Perrett, D. I., Völlm, B. A., Cowen, P. J., & Goodwin, G. M.
- Affiliations
- Warneford Hospital (GB)
- University of St Andrews (GB)
- Corresponding author
- Harmer, C J
- Venue
- Neuropsychopharmacology
- Published
- 2003-01
- Volume
- 28
- Issue
- 1
- Pages
- 148-152
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2055098509
- Cited by
- 420
- References
- 38
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 44 · 2020: 17 · 2019: 12 · 2018: 18 · 2017: 18 · 2016: 8 · 2015: 22 · 2014: 27 · 2013: 15 · 2012: 16
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Face Recognition and Perception
- Keywords
- citalopram, selective serotonin reuptake inhibitors, facial expression recognition, emotional processing, social information processing, serotonin, basic emotions, fear recognition, happiness recognition, mood, healthy female volunteers
- MeSH terms
- Adult, Affect, Anxiety, Cues, Double-Blind Method, Emotions, Facial Expression, Female, Humans, Middle Aged, Social Perception, Citalopram, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.